Table 1 Study group characteristics.
Characteristic | Study Groups | p-value | |
|---|---|---|---|
EC | TX | ||
n | 10 | 10 | |
Age (Years) | 46 [40–54] | 48 [45–52] | 0.43 |
Male (%) | 50 | 90 | 0.07 |
Viral load (copies/mL) | 50 | 50 | NA |
CD4 counts (cells/μL) | 1.235 [629–1474] | 820 [626–1.253] | 0.63 |
Length of infection (Years) | 13 [10–16] | 14 [12–17] | 0.66 |
Length of treatment (Years) | NA | 13 [10–17] | — |